Cargando…

Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go

Puerarin (Pue), known as a phytoestrogen, has salient bioactivities and is promising against cardiovascular diseases. This article summarizes the underlying molecular mechanisms of Pue in treating cardiovascular diseases, especially regulating the intracellular signal transduction, influencing ion c...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Weida, Guo, Jianghong, Gou, Wenfeng, Wu, Shaohua, Guo, Na, Zhao, Yuping, Hou, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476793/
https://www.ncbi.nlm.nih.gov/pubmed/36117660
http://dx.doi.org/10.1016/j.chmed.2021.12.003
_version_ 1784790216495595520
author Qin, Weida
Guo, Jianghong
Gou, Wenfeng
Wu, Shaohua
Guo, Na
Zhao, Yuping
Hou, Wenbin
author_facet Qin, Weida
Guo, Jianghong
Gou, Wenfeng
Wu, Shaohua
Guo, Na
Zhao, Yuping
Hou, Wenbin
author_sort Qin, Weida
collection PubMed
description Puerarin (Pue), known as a phytoestrogen, has salient bioactivities and is promising against cardiovascular diseases. This article summarizes the underlying molecular mechanisms of Pue in treating cardiovascular diseases, especially regulating the intracellular signal transduction, influencing ion channels, modulating the expression of microRNA, and impacting on the autophagy, which are mainly involved in the inflammatory signaling pathways, fatty acid/lipid metabolism, oxidative stress, apoptosis, and the like. The protective effect of Pue against cardiovascular diseases mainly involves attenuating the myocardial injury and decreasing the myocardial fibrosis, improving the myocardial ischemia/reperfusion injury, as well as inhibiting the myocardial hypertrophy and atherosclerosis. The molecular mechanisms of Pue’s cardiovascular protective effects for the first time and comment on the state-of-the-art research methods and principles of Pue’s regulation of small molecules were reviewed, so as to provide the rationale for its basic research and clinical applications.
format Online
Article
Text
id pubmed-9476793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94767932022-09-16 Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go Qin, Weida Guo, Jianghong Gou, Wenfeng Wu, Shaohua Guo, Na Zhao, Yuping Hou, Wenbin Chin Herb Med Review Puerarin (Pue), known as a phytoestrogen, has salient bioactivities and is promising against cardiovascular diseases. This article summarizes the underlying molecular mechanisms of Pue in treating cardiovascular diseases, especially regulating the intracellular signal transduction, influencing ion channels, modulating the expression of microRNA, and impacting on the autophagy, which are mainly involved in the inflammatory signaling pathways, fatty acid/lipid metabolism, oxidative stress, apoptosis, and the like. The protective effect of Pue against cardiovascular diseases mainly involves attenuating the myocardial injury and decreasing the myocardial fibrosis, improving the myocardial ischemia/reperfusion injury, as well as inhibiting the myocardial hypertrophy and atherosclerosis. The molecular mechanisms of Pue’s cardiovascular protective effects for the first time and comment on the state-of-the-art research methods and principles of Pue’s regulation of small molecules were reviewed, so as to provide the rationale for its basic research and clinical applications. Elsevier 2022-03-23 /pmc/articles/PMC9476793/ /pubmed/36117660 http://dx.doi.org/10.1016/j.chmed.2021.12.003 Text en © 2022 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Qin, Weida
Guo, Jianghong
Gou, Wenfeng
Wu, Shaohua
Guo, Na
Zhao, Yuping
Hou, Wenbin
Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go
title Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go
title_full Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go
title_fullStr Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go
title_full_unstemmed Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go
title_short Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go
title_sort molecular mechanisms of isoflavone puerarin against cardiovascular diseases: what we know and where we go
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476793/
https://www.ncbi.nlm.nih.gov/pubmed/36117660
http://dx.doi.org/10.1016/j.chmed.2021.12.003
work_keys_str_mv AT qinweida molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego
AT guojianghong molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego
AT gouwenfeng molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego
AT wushaohua molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego
AT guona molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego
AT zhaoyuping molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego
AT houwenbin molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego